Similar articles

• Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.

  Soonawala D, Middelburg RA, Egger M, Vandenbroucke JP, Dekkers OM. Soonawala D, et al. Int J Epidemiol. 2010 Dec;39(6):1567-81. doi: 10.1093/ije/dyq136. Epub 2010 Sep 13. Int J Epidemiol. 2010. PMID: 20837637
• Commentary: The debate on non-inferiority trials: 'when meta-analysis alone is not helpful'.

  Liberati A, D'Amico R. Liberati A, et al. Int J Epidemiol. 2010 Dec;39(6):1582-3. doi: 10.1093/ije/dyq197. Int J Epidemiol. 2010. PMID: 21113051 No abstract available.
• 7 questions to ask when evaluating a noninferiority trial.

  Mounsey A, Viera AJ, Dominik R. Mounsey A, et al. J Fam Pract. 2014 Mar;63(3):E4-8. J Fam Pract. 2014. PMID: 24701606 No abstract available.
• Designs for efficient clinical trials.

  Simon R. Simon R. Oncology (Williston Park). 1989 Jul;3(7):43-9; discussion 51-3. Oncology (Williston Park). 1989. PMID: 2701811 Review.
• Therapeutic equivalence investigations: statistical considerations.

  Röhmel J. Röhmel J. Stat Med. 1998 Aug 15-30;17(15-16):1703-14. doi: 10.1002/(sici)1097-0258(19980815/30)17:15/16<1703::aid-sim972>3.0.co;2-g. Stat Med. 1998. PMID: 9749441 Review.